Skip to contentApplication 213570
- Type
- ANDA
- Sponsor
- SANDOZ INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | REXULTI | BREXPIPRAZOLE | TABLET; ORAL | 0.25MG | No | No |
| 002 | REXULTI | BREXPIPRAZOLE | TABLET; ORAL | 0.50MG | No | No |
| 003 | REXULTI | BREXPIPRAZOLE | TABLET; ORAL | 1MG | No | No |
| 004 | REXULTI | BREXPIPRAZOLE | TABLET; ORAL | 2MG | No | No |
| 005 | REXULTI | BREXPIPRAZOLE | TABLET; ORAL | 3MG | No | No |
| 006 | REXULTI | BREXPIPRAZOLE | TABLET; ORAL | 4MG | No | No |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 72161 | ORIG | 2022-09-27 |